PMID: 41913218
A biology-based quality-diversity algorithm for drug repurposing in Alzheimer's disease using automated machine learning.
Shao Sisi, Ribeiro Pedro Henrique, Orlenko Alena et al.
BioData mining · 2026
Research Library
Exemestane
36 papers indexed
PMID: 42370139
A case report of synchronous bilateral breast cancer with distinct histological subtypes and favorable long-term survival.
Zhang PingBo, Zhao DaWei
Frontiers in oncology · 2026
PMID: 42574969
A phase II study of androgen receptor inhibition by darolutamide in combination with leuprolide acetate and exemestane in recurrent adult-type ovarian granulosa cell tumor.
Hopp Elizabeth E, Enserro Danielle, Campos Susana et al.
Gynecologic oncology · 2026
PMID: 42462461
AKR1C3 and CLIC3 mediate the comorbidity of diabetic foot ulcers and hypercholesterolemia via the TGF-β/lipid metabolism axis.
Xu Yueyuan, Li Youshan, Wu Chunyuan
Biochemical and biophysical research communications · 2026
PMID: 41964675
Association study of aromatase inhibitors and adverse events related to osteoporosis: based on pharmacovigilance data.
Yang Nan, Zhang Wei, Cui Xinliang et al.
Naunyn-Schmiedeberg's archives of pharmacology · 2026
PMID: 41681940
Comparison Between Alpelisib Plus Endocrine Therapy and Everolimus Plus Endocrine Therapy After CDK4/6 Inhibitors Progression in Patients with PIK3CA -Mutant Metastatic Breast Cancer: A Single-Center Retrospective Study.
Loizidis Sotiris, Michaelides Damianos, Marcou Yiola et al.
Cancers · 2026
PMID: 42327682
Correction: Methotrexate-lactoferrin targeted exemestane cubosomes for synergistic breast cancer therapy.
Mokhtar Sarah, Khattab Sherine N, Elkhodairy Kadria A et al.
Frontiers in chemistry · 2026
PMID: 42564046
Development and characterization of an injectable thermoresponsive PLGA nanoparticle-loaded in situ gel for sustained exemestane delivery.
Singh Priya, Swain Namrata, Shamim Shagufa et al.
Frontiers in oncology · 2026
PMID: 42314298
Effects of dietary exemestane administration on reproductive performance, hepatic function, and lipid metabolism in Japanese quail.
Hadavi Mohammad Amin, Najafi Abouzar, Sharifi Seyed Davood et al.
Poultry science · 2026
PMID: 42447938
Exemestane chronic exposure induces cardiotoxicity by disrupting calcium homeostasis and endothelin pathway: Evidence from biochemical, radiological and histopathological analyses.
Alotaibi Reem Nasser, Hayat Muhammad Faisal, Jamil Salim et al.
The Journal of steroid biochemistry and molecular biology · 2026
PMID: 42055200
Exemestane induces neurodevelopmental defects and behavioral diorder in zebrafish embryos by p53 signaling pathway.
Li Weirong, Hu Weitao, Ge Chenkai et al.
Comparative biochemistry and physiology. Toxicology & pharmacology : CBP · 2026
PMID: 42229584
Final outcomes of the SOFT and TEXT phase III trials in premenopausal hormone receptor-positive early breast cancer.
Francis P A, Pagani O, Fleming G F et al.
Annals of oncology : official journal of the European Society for Medical Oncology · 2026
PMID: 42467326
Green synthesized cobalt doped graphene quantum dots derived from Boswellia serrata for dual ligand targeted bioimaging and delivery of exemestane.
Harde Minal T, Ingle Rahul, Dhamal Sakshi et al.
Discover nano · 2026
PMID: 41536874
Incidental pulmonary leiomyoma in a patient with invasive mucinous breast carcinoma: A diagnostic challenge.
Alsaleh Bano, Alanzi Ahmed, Alatefi Dawood et al.
Radiology case reports · 2026
PMID: 41551935
Integrative Bioinformatics and Machine Learning Identify Novel Diagnostic Biomarkers and Molecular Mechanisms in Sjögren's Syndrome.
Xu Hua, Liu Yong, Song Yuyin et al.
International journal of genomics · 2026
PMID: 42450048
Intravenous Everolimus Formulation (Sapu003) for Clinical Trials.
Min Sheng-Hao, Forero Kevin, Putnam William et al.
International journal of molecular sciences · 2026
PMID: 42267201
Lichenoid drug eruption induced by letrozole: a case report.
Alhusaini Yara M, Almufadhi Abdulaziz A, Sayed Ayah K et al.
Oxford medical case reports · 2026
PMID: 41863173
Ligand and Structure-Based Drug Design of Biphenyl 1,2,4-Triazole Derivatives as Dual Target Inhibitors of Aromatase and Steroidal Sulfatase as Anti-Breast Cancer Agents.
Vivekananthan G, Subramaniam Varun Sankar Siva, Sruthi N J Sai et al.
Current medicinal chemistry · 2026
PMID: 41727395
Metastatic lobular breast cancer masquerading as achalasia.
Javed Abid, Dreyer Justin, Cassidy Daniel et al.
VideoGIE : an official video journal of the American Society for Gastrointestinal Endoscopy · 2026
PMID: 41632158
Outcomes of Anastrozole, Letrozole, and Exemestane in Patients With Postmenopausal Breast Cancer.
Dumas Elise, Hamy Anne-Sophie, Wanis Kerollos Nashat et al.
JAMA network open · 2026
PMID: 42405609
Ovarian Function Suppression in Premenopausal Hormone Receptor-Positive Early Breast Cancer: A Comprehensive Review.
Park Woong Ki, Ryu Jai Min
Journal of breast cancer · 2026
PMID: 41962306
Patient-reported outcomes and qualitative interviews in patients with estrogen receptor-positive/human epidermal growth factor receptor 2-negative advanced breast cancer: results from the phase III EMBER-3 trial.
Curigliano G, O'Shaughnessy J, Bidard F-C et al.
ESMO open · 2026
PMID: 42190242
Planning and Developing a Symptom Diary Intervention for Breast Cancer Survivors With Concerns About Medication Brands (ENABLE Study): User-Centered Design Approach.
Eraso Yolanda, Stewart Duncan, Edwards Ruth et al.
JMIR cancer · 2026
PMID: 41840087
Prevalence, severity and associated risk factors of symptomatic dry eye among breast cancer patients receiving systemic therapy in Palestine.
Al Nuaimi Zaina, Abualrub Nadin, Abu Amr Du'aa et al.
Scientific reports · 2026
PMID: 42078676
Rapid Hemostasis and Significant Tumor Regression in Ulcerative Breast Cancer Via Combined Modified Lattice Radiotherapy and Systemic Therapy: A Case Report.
Sang Weiwei, Shi Yanyan, Wang Bin et al.
Breast cancer : basic and clinical research · 2026
PMID: 41970155
Recurrent Radiation-Induced Angiosarcoma of the Breast Without Distant Metastasis: A Case Report.
Bivolarski Ivan, Dimitrov Martin
Cureus · 2026
PMID: 42061370
Safety and antitumour activity of ipatasertib combined with endocrine therapy and a CDK4/6 inhibitor in HR+/HER2- metastatic breast cancer (TAKTIC): a single-centre, open-label, phase 1b trial.
Wander Seth A, Lloyd Maxwell R, Keenan Jennifer C et al.
The Lancet. Oncology · 2026
PMID: 41937464
Screening of Anabolic Androgenic Steroids in Illicit Dietary Supplements and Counterfeit Drugs Using LC-MS/MS and LC-QTOF/MS.
Kim Hyunsuk, Seo Sowoon, Kim Aeseul et al.
Drug testing and analysis · 2026
PMID: 41930299
Second-line therapies after CDK4/6 inhibitor failure in HR-positive/HER2-negative metastatic breast cancer patients: real-world data from the HERMIONE-13 study.
Cazzaniga M E, Cogliati V, Rossi E et al.
ESMO real world data and digital oncology · 2026
PMID: 42210941
Sequential CDK4/6 inhibition in bone-only metastatic HR+/HER2- breast cancer: a case of prolonged disease control with abemaciclib after clinical progression on palbociclib-based therapy.
Peng Xuejiao, Chang Weiqin
Frontiers in medicine · 2026
PMID: 42541454
Signal Detection and Temporal Analysis of Aromatase Inhibitor-Associated Hepatotoxicity: A Pharmacovigilance Study Integrating Bayesian Belief-Propagation Network and Frequentist Metrics.
Li Yuke, Zheng Hongmei, Wang Yanting et al.
The international journal of medical robotics + computer assisted surgery : MRCAS · 2026
PMID: 41551023
Strategies to inhibit steroid cytochrome P450 enzymes to benefit human health: development of steroid ligands for P450s 17A1, 19A1, and 8B1 to treat cancer and obesity.
Ho Tu M, Yoshimoto Francis K
RSC medicinal chemistry · 2026
PMID: 41994631
Tamoxifen-induced neutropenia and leukopenia in a breast cancer patient: a case report and literature review.
Liu Cheng, Xu Fadong, Liu Qinglai
Frontiers in oncology · 2026
PMID: 41980703
Transfer Learning and Machine Learning for Training Five-Year Survival Prognostic Models in Early Breast Cancer: Development and Validation Study.
Pilgram Lisa, Yang Kai, Beltran-Bless Ana-Alicia et al.
Journal of medical Internet research · 2026
PMID: 41678931
Treatment of ER-positive breast cancer with FDA-approved aromatase inhibitors.
Kim Nayoung, Lukong Kiven Erique
Cancer treatment and research communications · 2026
PMID: 42482750
Unveiling the tendon toxicity spectrum of anastrozole, letrozole, and exemestane: a real-world pharmacovigilance study.
Zhao Shuai, Xu Lu-Yao, Chen Ping et al.
Frontiers in oncology · 2026
For research use only. This index links to third-party literature. Nothing here constitutes medical advice.